ELDISINE vindesine sulfate 5mg powder for injection vial

국가: 오스트레일리아

언어: 영어

출처: Department of Health (Therapeutic Goods Administration)

유효 성분:

vindesine sulfate, Quantity: 5 mg

제공처:

Aspen Pharmacare Australia Pty Ltd

약제 형태:

Injection, powder for

구성:

Excipient Ingredients: mannitol

관리 경로:

Intravenous

패키지 단위:

1 vial of powder 5mg

처방전 유형:

(S4) Prescription Only Medicine

치료 징후:

This product accepted for registration/listing as 'currently supplied' at the time of commencement of the Act. Indications held in ARTG paper records. (Old code) ELDISINE is indicated in the palliative treatment of the following: Acute lymphocytic leukaemia of childhood resistant to other agents. Blastic crises of chronic myeloid leukaemia in adults. Non-small cell lung cancer. It should be noted that ELDISINE is usually given in combination with other oncolytic agents.

제품 요약:

Visual Identification: A white to off-white lyophilised plug; Container Type: Vial; Container Life Time: 3 Years; Container Temperature: Store at 2 to 8 degrees Celsius

승인 상태:

Licence status A

승인 날짜:

1997-08-14